Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Agios Pharmaceuticals Inc (AGIO)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Casdin Capital

Eli Casdin

295,000 $16,865 +16% 4.1%
2.
Opaleye Management

James A. Silverman

130,000 $7,432 2.37%
3.
Opus Point Partners Management

Michael S. Weiss And Lindsay A. Rosenwald

28,704 $1,641 -14% 1.41%
4.
Deerfield Management

James E. Flynn

262,984 $15,035 +27% 0.59%
5. 20,019 $1,144 0.42%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$83.44 200 Director 571 2018-03-16 Filing
$67.00 851,154 Large Shareholder 1,374,599 2018-01-23 Filing
$67.00 851,154 Large Shareholder 1,374,599 2018-01-23 Filing
$49.50 624,575 Large Shareholder 1,856,353 2017-04-24 Filing
$110.75 1,806 Director 50,689 2014-12-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$85.68 700 Officer 881 2018-04-12 Filing
$84.78 1,300 Officer 1,581 2018-04-12 Filing
$77.17 500 Officer 57,196 2018-04-05 Filing
$76.17 800 Officer 57,696 2018-04-05 Filing
$75.04 400 Officer 58,496 2018-04-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 95,000 $7,769 0.95%
2. 4,874 $399 0.09%
3. 0 $0 0%
4. 4,860 $397 0%
News See All